Are endectocides the future of parasite control?

As a vet and a parasitologist, I always have a keen interest (and perhaps a little bit of excitement) when new products are launched for parasite control in cats and dogs. When I first graduated in 2002, the holy grail of cat and dog parasite control was a product which treated ticks, fleas, tapeworm and roundworm, allowing all UK parasites of significance (Angiostrongylus vasorum had yet to start its campaign to conquer the UK) to be eliminated in one fell swoop. It took many years for anything close to this to be released. Recently, several products have been launched for dogs that come close to ticking all of these boxes, along with one that treats all four groups of parasite (five including lungworm) in cats. Given that an evidence and risk-based approach is now encouraged for routine parasite treatment, the question is do these products, known as broad spectrum endectocides, still represent the future of parasite control or are they an aspiration of the past?